Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

European Stock Futures Edge Higher; German GDP Rebounds

Published 08/24/2021, 02:06 AM
Updated 08/24/2021, 02:07 AM
© Reuters.

© Reuters.

By Peter Nurse 

Investing.com - European stock markets are expected to edge higher at the open Tuesday, helped by a strong handover from Wall Street after the full approval of a Covid-19 vaccine as well as signs of strong German growth.

At 2:05 AM ET (0605 GMT), the DAX futures contract in Germany traded 0.1% higher, CAC 40 futures in France climbed 0.4% and the FTSE 100 futures contract in the U.K. rose 0.1%.

Helping the sentiment on the European markets Tuesday were the strong gains on Wall Street overnight, with the tech-heavy Nasdaq Composite jumping 1.6% to a record closing high, after the U.S. Food and Drug Administration granted full approval to the Covid-19 vaccine developed by Pfizer (NYSE:PFE) and BioNTech (DE:22UAy).

Surging numbers of coronavirus cases caused by the highly contagious delta variant have fueled concerns that the U.S. economic recovery will be stunted, but this move could accelerate inoculations as companies mandate jabs in order to return to the office.

Back in Europe, the German economy grew a little faster than expected in the second quarter, by 1.6% on the quarter, climbing 9.4% on the year, according to the country’s final reading on the economy's rate of growth. That's a sharp rebound from the first quarter’s decline but it has been overshadowed by the Bundesbank's announcement on Monday that the country may miss full-year growth targets due to the delta variant. 

Investors are also keeping a wary eye on the situation in Afghanistan, with leaders from the Group of Seven industrial countries set to hold a virtual meeting later Tuesday to discuss the situation.

However, the main focus this week will be on the Federal Reserve’s Jackson Hole symposium that opens on Aug. 26, where further clues on the timeline for the U.S. central bank’s planning on asset tapering and interest rate hikes are expected.

In corporate news, the U.K. grocery market is likely to remain in focus after WM Morrison (LON:MRW) agreed to CD&R’s new $9.54 billion takeover bid, while rival J Sainsbury 's (LON:SBRY) stock soared Monday following a report that private equity firms were also looking at this chain.

Elsewhere, oil prices edged higher, continuing Monday’s sharp rebound with the U.S. regulatory body’s full approval of the Pfizer/BioNTech Covid-19 vaccine boosting hopes that greater vaccination levels will lead to a boost in fuel demand.

Investors now await U.S. crude oil supply data from the American Petroleum Institute, due later in the day, amid expectations for a hefty fall in inventories ahead of Labor Day weekend.

By 2:05 AM ET, U.S. crude futures traded 0.3% higher at $65.86 a barrel, while the Brent contract rose 0.4% to $68.63. Both contracts jumped more than 5% on Monday after recording their biggest week of losses in more than nine months last week.

Additionally, gold futures rose 0.1% to $1,805.05/oz, while EUR/USD traded largely flat at 1.1744.

 

Latest comments

Powell is riding on the stimulus lion; he does not know how to get off the lion and be safe from the lion. sooner or later he will have to get off the lion 🦁 and the lion will get him alive. this type of circus tricks are not without the risks. Monkey rides on lion and gets eaten alive
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.